Spontan/roxus

* Pearlman and Riester discuss why treatment timing remains an important consideration for many men with ED and how rapid absorption through the nasal mucosa could support a more spontaneous sexual experience. * T-max median of 10 minutes In this episode of Pearls & Perspectives, host Amy...

* Positive feedback from 400+ Restorative Health Clinic patients In this video, I give you my honest opinion of Spontan, the new nasal spray treatment for erectile dysfunction (ED) now available in Australia. Why should you listen to me? I'm a Urology NP and Clinical Sexologist at...

https://www.theaustralian.com.au/business/stockhead/content/clinical-data-for-ltr-pharmas-ed-nasal-spray-published-in-peerreviewed-journal/news-story/e02495d17c9fc3d21c8dedda88f91b3b Key clinical findings included: Ultra-rapid onset – SPONTAN reached peak plasma concentration (Tmax) in a...

* Dr Andrew Sun, said: "A sizeable portion of patients experience problematic side effects from higher-dose PDE5 tablets –back pain, heartburn, joint aches–that affect quality of life and intimacy. ROXUS AND SPONTAN offer the rapid onset men want without the systemic side effects that often...

US launch 2026! UP YOUR NOSE AND UP IT GOES LOL! * It’s also gearing up to launch a new product Roxus, another nasal spray which could help gain access to the US healthcare market Tylah Tully chats with LTR Pharma (ASX:LTP) executive chairman Lee Rodne about its successful...

JMM-Biotech-Forum-Presentation

Launching in the US early 2026! * two nasal spray formulations—Spontan and Roxus—both based on the proven compound vardenafil. * LTR Pharma has announced that it will launch its new product Roxus in the US market in the first half of 2026. Instead of waiting for full regulatory approval...